SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-24-030479
Filing Date
2024-04-04
Accepted
2024-04-04 17:10:57
Documents
5

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT ea0203318-01.htm POS AM 636760
2 OPINION OF GREENBERG TRAURIG, P.A, U.S. COUNSEL TO THE REGISTRANT ea020331801ex5-2_neuro.htm EX-5.2 15444
3 CONSENT OF SOMEKH CHAIKIN (MEMBER FIRM OF KPMG INTERNATIONAL), INDEPENDENT REGIS ea020331801ex23-1_neuro.htm EX-23.1 2191
4 GRAPHIC ex5-2_001.jpg GRAPHIC 7403
5 GRAPHIC tneuro_logo.jpg GRAPHIC 117135
  Complete submission text file 0001213900-24-030479.txt   827251
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-273375 | Film No.: 24823910
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)